Chad Hamilton to Drug Resistance, Neoplasm
This is a "connection" page, showing publications Chad Hamilton has written about Drug Resistance, Neoplasm.
Connection Strength
0.354
-
Establishment and characterization of a platinum- and paclitaxel-resistant high grade serous ovarian carcinoma cell line. Hum Cell. 2017 Jul; 30(3):226-236.
Score: 0.128
-
Elevated AKAP12 in paclitaxel-resistant serous ovarian cancer cells is prognostic and predictive of poor survival in patients. J Proteome Res. 2015 Apr 03; 14(4):1900-10.
Score: 0.112
-
Jupiter microtubule-associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers. Cancer Med. 2020 02; 9(3):1092-1103.
Score: 0.039
-
Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells. Gynecol Oncol. 2015 Mar; 136(3):554-61.
Score: 0.027
-
Identification of candidate circulating cisplatin-resistant biomarkers from epithelial ovarian carcinoma cell secretomes. Br J Cancer. 2014 Jan 07; 110(1):123-32.
Score: 0.025
-
Mitochondrial proteomic analysis of cisplatin resistance in ovarian cancer. J Proteome Res. 2012 Sep 07; 11(9):4605-14.
Score: 0.023